Press release
Movement Disorders Market: Product Innovation to Underscore Significant Growth Opportunities
Fact.MR
Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=329
Increasing instances of abnormal and uncontrolled movements among patients has been indicative of neurological diseases. As the need to detect prevalence of a neurological disease persists, leading healthcare companies are banking on this opportunity and offering effective treatment solutions. In order to offer effective medical devices, manufacturers in the medical device industry are incorporating innovative and intelligent technology such as bioinformatics, nanotechnology, and molecular targeting. Through incorporation of innovating and cutting-edge technology, leading companies are focusing on product innovation and differentiation to attain a competitive edge over the other market players.
Rapid development in medical technology has enabled the leading manufacturers to integrate advanced features such as cloud technology, sensors, and 360 degree stabilizing solutions. Manufacturers are focusing on incorporating innovative solutions that record and store the information regarding the tremor patterns of the patient. On the basis of this, the medical devices generate an algorithm of the patterns for optimum stabilization. Leading companies are focusing on offering products equipped with technologically enhanced features to expand their customer base in the global market.
Over US$ 1,000 Mn Opportunity in Global Movement Disorders Market
According to Fact.MR, the global movement disorders market is expected to reach a value of more than US$ 1,000 Mn by the end of 2026. Prevalence of diseases such as cerebrovascular diseases, trauma, degenerative diseases, convulsive diseases, and brain tumor has led to surge in demand for movement disorder treatments and medication. As the need to treat neurological disorder persist, leading companies are focusing on incorporating advanced technological features for better treatment solutions. Innovative products such as electronic stabilizing handle for patients of Parkinson’s disease include soup spoons, spork, spoons, and fork for everyday use. In addition, Xadago tablets and Ingrezza capsules are some of the medications that have cleared the FDA pipeline. Xadago (safinamide) tablets are prescribed for Parkinson’s disease, whereas Ingrezza capsules are prescribed for dyskinesia. Further, FDA has also given approval for implanting brain in order to lower the impact of tremors. Increase in product launches and innovation is expected to impact growth of the global market positively.
As the need for neurological disorders is expected to increase, demand for rechargeable deep brain stimulator devices will continue to remain high. In terms of revenue, the rechargeable deep brain stimulator devices in the global market by the end of 2026. However, rechargeable deep brain stimulator products is expected to represent the fastest growth in the global market throughout 2026.
Browse Full Report with TOC @https://www.factmr.com/report/329/movement-disorder-market
Sales of the medical devices for the treatment of neurological disorders through hospitals is likely to generate significant revenues by the end of 2017. However, sales of medical equipment through clinics will continue to witness the fastest growth in the global market through 2026. Demand for the medical devices for treatment of the neurological disorders is expected to remain concentrated towards Parkinson’s diseases in the healthcare industry. Throughout 2026, sales of medical devices for the treatment of dystonia diseases is expected to register the fastest growth in the global market.
Major market players operating in the global market include Mayo Clinic, Boston Scientific Corporation, Abbott Laboratories, and Medtronic Plc.
Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=329
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare Market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Movement Disorders Market: Product Innovation to Underscore Significant Growth Opportunities here
News-ID: 1018258 • Views: …
More Releases from Fact.MR
Silicon Anode Slurries Market Forecast 2026-2036: Market Size, Share, Competitiv …
The global silicon anode slurries market is set for significant expansion between 2026 and 2036, fueled by the rising adoption of high-energy-density lithium-ion batteries across electric vehicles (EVs), consumer electronics, and grid-scale energy storage. As battery manufacturers increasingly transition from graphite to silicon-enhanced anodes, the demand for high-performance, scalable silicon anode slurries is projected to grow sharply.
To access the complete data tables and in-depth insights, request a Discount On The…
Silicon Anode Slurries Market Forecast 2026-2036: Market Size, Share, Competitiv …
The global silicon anode slurries market is set for significant expansion between 2026 and 2036, fueled by the rising adoption of high-energy-density lithium-ion batteries across electric vehicles (EVs), consumer electronics, and grid-scale energy storage. As battery manufacturers increasingly transition from graphite to silicon-enhanced anodes, the demand for high-performance, scalable silicon anode slurries is projected to grow sharply.
To access the complete data tables and in-depth insights, request a Discount On The…
Low-Siloxane Cleanroom Wall Coatings Market Deep-Dive 2026-2036: Strategic Forec …
The low-siloxane cleanroom wall coatings market is poised for steady growth over the next decade, driven by rising contamination-control requirements across semiconductor, pharmaceutical, biotechnology, and precision manufacturing industries. These coatings are specifically engineered to minimize siloxane outgassing and volatile organic compound emissions, helping maintain ultra-clean environments where even trace contamination can disrupt production quality.
By 2036, the market for low-siloxane cleanroom wall coatings is expected to grow to USD 91.04 million.…
Low-Siloxane Cleanroom Wall Coatings Market Deep-Dive 2026-2036: Strategic Forec …
The low-siloxane cleanroom wall coatings market is poised for steady growth over the next decade, driven by rising contamination-control requirements across semiconductor, pharmaceutical, biotechnology, and precision manufacturing industries. These coatings are specifically engineered to minimize siloxane outgassing and volatile organic compound emissions, helping maintain ultra-clean environments where even trace contamination can disrupt production quality.
By 2036, the market for low-siloxane cleanroom wall coatings is expected to grow to USD 91.04 million.…
More Releases for Parkinson’s
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082
The report provides a comprehensive analysis of company profiles listed below:
- Teva
- Roche
- Prothena
- Acorda…
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson’s Disease Treatment with respect…
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds…
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that…
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports.
Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,…
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent.
Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial…
